135 related articles for article (PubMed ID: 1465811)
1. Fully parametric analysis of kidney graft survival.
Vereerstraeten P
Transplant Proc; 1992 Dec; 24(6):2411-3. PubMed ID: 1465811
[No Abstract] [Full Text] [Related]
2. Influence of HLA antigens of renal transplant recipients on graft survival.
Alamartine E; Berthoux F; Acquart S; Lepetit JC
Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
[No Abstract] [Full Text] [Related]
3. The graft survival curve: ideology and rhetoric.
Guttmann RD
Transplant Proc; 1992 Dec; 24(6):2407-10. PubMed ID: 1465810
[No Abstract] [Full Text] [Related]
4. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
Pallardó LM; Sánchez J; Sánchez P; García J; Orero E; Beneyto I; Ros F
Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
[No Abstract] [Full Text] [Related]
5. Cold ischemia time and MHC class II matching in renal transplants.
Iwaki Y; Cicciarelli J; Aswad S; Gavazov M; Obispo E; Khetan U; Bogaard T; Asai P; Mendez RG; Mendez R
Transplant Proc; 1992 Dec; 24(6):2456-7. PubMed ID: 1465829
[No Abstract] [Full Text] [Related]
6. Autoreactive IgM non-HLA antibodies are not entirely clinically irrelevant. The Manchester UK Kidney Transplant Team.
Martin S; Dyer PA; Scott PD
Transplant Proc; 1992 Dec; 24(6):2504. PubMed ID: 1465846
[No Abstract] [Full Text] [Related]
7. Enhanced renal graft survival in HLA-A mismatched transplants.
Bućin D; Ekberg H; Lindholm A; Persson H; Tufvesson G; Albrechtsen D
Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
[No Abstract] [Full Text] [Related]
8. Influence of HLA matching on the outcome of kidney transplants in a single center analysis.
Schanz D; Blümke M; Keller E; Tanzi-Fetta RF; Kirste G
Transplant Proc; 1992 Dec; 24(6):2455. PubMed ID: 1465828
[No Abstract] [Full Text] [Related]
9. Influence of recipient's HLA type on the outcome of renal transplantation.
Forsberg B; Ekberg H; Johnson U
Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
[No Abstract] [Full Text] [Related]
10. HLA-A, B, DR antigens and renal transplantation from cadaveric donors and living-related donors in Greek patients.
Adam K; Polymenidis Z; Papakyriazi L; Alexopoulos E; Parapanissiou E; Antoniadis A; Papadimitriou M
Transplant Proc; 1992 Dec; 24(6):2449-50. PubMed ID: 1465825
[No Abstract] [Full Text] [Related]
11. Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients.
Cristol JP; Mourad G; Argiles A; Seignalet J; Iborra F; Ramounau-Pigot A; Chong G; Mion C
Transplant Proc; 1992 Dec; 24(6):2470-1. PubMed ID: 1465835
[No Abstract] [Full Text] [Related]
12. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
Polymenidis Z; Adam K; Parapanissiou E; Sakellariou G; Papakyriazi E; Antoniadis A; Papadimitriou M
Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
[No Abstract] [Full Text] [Related]
13. Effect of donor-specific blood transfusions on graft outcome in live donor renal transplantations.
Velidedeoğlu E; Tokyay R; Haberal M
Transplant Proc; 1992 Dec; 24(6):2752-3. PubMed ID: 1465927
[No Abstract] [Full Text] [Related]
14. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
[No Abstract] [Full Text] [Related]
15. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
Keitel E; Bittar AE; Losekann A; Deboni L; Ceretta F; Goldani JC; Garcia VD
Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
[No Abstract] [Full Text] [Related]
16. Measures to improve early results in kidney transplantation.
Schweizer RT; Roper L; Hull D; Bartus S
Transplant Proc; 1992 Dec; 24(6):2729-30. PubMed ID: 1465919
[No Abstract] [Full Text] [Related]
17. Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant.
Leivestad T; Berger L; Thorsby E
Transplant Proc; 1992 Dec; 24(6):2447-8. PubMed ID: 1465824
[No Abstract] [Full Text] [Related]
18. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
[No Abstract] [Full Text] [Related]
19. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G
Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
[No Abstract] [Full Text] [Related]
20. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
